Aronora
OR - Portland
BiotechnologyFocus: Recombinant monoclonal antibodies and enzymes
Aronora is a life sciences company focused on Recombinant monoclonal antibodies and enzymes.
CardiovascularNephrology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
xisomab 3G3- Dose 1
ThrombosisClinical Trials (1)
NCT03097341Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects
Phase 1E-WE Thrombin- Dose 1
ThrombosisClinical Trials (1)
NCT03453060Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects
Phase 1AB023- Dose 1
End Stage Renal DiseaseClinical Trials (1)
NCT03612856Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
Phase 2AB002 Dose 1
End Stage Renal DiseaseClinical Trials (1)
NCT03963895Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 4 clinical trials
Top TAs: Cardiovascular, Nephrology
Publications: 25 in PubMed